U.S. Physical Therapy (NYSE:USPH – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued to investors on Thursday.
Several other analysts also recently commented on USPH. William Blair reiterated a “market perform” rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. JMP Securities reaffirmed a “market outperform” rating and set a $113.00 price objective on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd. Barrington Research cut their price target on U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating for the company in a research note on Friday, February 28th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating on the stock in a research report on Wednesday, March 19th. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $109.00.
Read Our Latest Stock Report on USPH
U.S. Physical Therapy Trading Up 3.9 %
U.S. Physical Therapy (NYSE:USPH – Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.02. The business had revenue of $183.79 million during the quarter, compared to the consensus estimate of $176.78 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The business’s quarterly revenue was up 18.0% on a year-over-year basis. During the same period in the previous year, the business earned $0.51 EPS. On average, sell-side analysts expect that U.S. Physical Therapy will post 2.67 earnings per share for the current fiscal year.
Insider Buying and Selling
In related news, COO Graham D. Reeve sold 1,730 shares of the company’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the sale, the chief operating officer now owns 7,168 shares in the company, valued at $588,564.48. This represents a 19.44 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 2.00% of the stock is owned by insiders.
Institutional Inflows and Outflows
A number of hedge funds have recently made changes to their positions in USPH. HighTower Advisors LLC increased its stake in U.S. Physical Therapy by 2.5% in the fourth quarter. HighTower Advisors LLC now owns 4,833 shares of the company’s stock valued at $429,000 after purchasing an additional 119 shares during the last quarter. CBIZ Investment Advisory Services LLC increased its stake in shares of U.S. Physical Therapy by 59.8% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock valued at $29,000 after acquiring an additional 122 shares during the last quarter. Albert D Mason Inc. boosted its position in shares of U.S. Physical Therapy by 1.3% in the fourth quarter. Albert D Mason Inc. now owns 10,596 shares of the company’s stock worth $940,000 after acquiring an additional 139 shares during the last quarter. Portside Wealth Group LLC boosted its position in shares of U.S. Physical Therapy by 3.9% in the first quarter. Portside Wealth Group LLC now owns 4,108 shares of the company’s stock worth $297,000 after acquiring an additional 154 shares during the last quarter. Finally, Harbor Capital Advisors Inc. increased its position in U.S. Physical Therapy by 1.0% during the fourth quarter. Harbor Capital Advisors Inc. now owns 16,344 shares of the company’s stock worth $1,450,000 after purchasing an additional 156 shares during the last quarter.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Featured Stories
- Five stocks we like better than U.S. Physical Therapy
- How to buy stock: A step-by-step guide for beginnersÂ
- Google Is Betting Big on Nuclear Reactors—Should You?
- Which Wall Street Analysts are the Most Accurate?
- Taiwan Semiconductor Has a New Reason to Rally on Chip Curbs
- How to start investing in penny stocks
- Why Nearly 20 Analysts Raised Meta Price Targets Post-Earnings
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.